{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:06:43Z","timestamp":1789189603527,"version":"build-2803163510"},"reference-count":68,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["26-15-00011"],"award-info":[{"award-number":["26-15-00011"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"award":["26-15-00011"],"award-info":[{"award-number":["26-15-00011"]}],"id":[{"id":"https:\/\/ror.org\/03y2gwe85","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>This narrative review summarizes current data on the role of desialylation of low-density lipoproteins (LDL) as a key initiating mechanism of atherogenesis that precedes oxidative modification. The structural and functional significance of sialic acid in apolipoprotein B-100 is considered, and the enzymes of the sialidase (neuraminidase) family responsible for its cleavage are characterized. The pathogenic role of increased sialidase activity in atherosclerosis, type 2 diabetes mellitus, and other diseases is discussed. The advantages of using dietary supplements based on natural sialidase inhibitors for long-term prevention compared with synthetic drugs are shown. Examples of already existing dietary supplements with antiatherosclerotic effects are described. A separate section is devoted to computer methods (molecular docking) for searching for new sialidase inhibitors among flavonoids; according to virtual screening data, gallated catechins were identified as the most promising candidates. The feasibility of further experimental and clinical studies to create effective and safe nutraceuticals that affect the early stages of atherogenesis is substantiated.<\/jats:p>","DOI":"10.3390\/biom16091319","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:54:19Z","timestamp":1789055659000},"page":"1319","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perspectives of Natural Products and Sialic Acid Mimetics as Modulators of Human Sialidases NEU1\u20133 in Atherosclerosis"],"prefix":"10.3390","volume":"16","author":[{"given":"Tatyana I.","family":"Kovyanova","sequence":"first","affiliation":[{"name":"Institute for Atherosclerosis Research, 4-1-207, Osennyaya Street, 121609 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0501-8499","authenticated-orcid":false,"given":"Vasily P.","family":"Karagodin","sequence":"additional","affiliation":[{"name":"Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 8, Baltiiskaya Street, 125315 Moscow, Russia"},{"name":"Department of Commodity Science and Commodity Expertise, Plekhanov Russian University of Economics, 36, Stremyanny Lant, 117997 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3596-5470","authenticated-orcid":false,"given":"Daria D.","family":"Borodko","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetic Modeling of Inflamaging, Institute of General Pathology, 8, Baltiiskaya Street, 125315 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulyana V.","family":"Rozhkova","sequence":"additional","affiliation":[{"name":"Institute for Atherosclerosis Research, 4-1-207, Osennyaya Street, 121609 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6866-7077","authenticated-orcid":false,"given":"Stanislav A.","family":"Antonov","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetic Modeling of Inflamaging, Institute of General Pathology, 8, Baltiiskaya Street, 125315 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra S.","family":"Utkina","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetic Modeling of Inflamaging, Institute of Pathophysiology, 8, Baltiiskaya Street, 125315 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0101-1065","authenticated-orcid":false,"given":"Anastasia N.","family":"Vaganova","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and Molecular Pharmacology, Institute of Translational Biomedicine, St. Petersburg State University, Universitetskaya Nab. 7\/9, 199034 St. Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"ref_1","first-page":"16","article-title":"LDL-Cholesterol: The Lower the Better","volume":"31","year":"2019","journal-title":"Clin. Investig. Arterioscler."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MOL.0b013e32834adadb","article-title":"Receptor-Independent Fluid-Phase Pinocytosis Mechanisms for Induction of Foam Cell Formation with Native Low-Density Lipoprotein Particles","volume":"22","author":"Kruth","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13238-012-2025-6","article-title":"Lipid Homeostasis and the Formation of Macrophage-Derived Foam Cells in Atherosclerosis","volume":"3","author":"Yuan","year":"2012","journal-title":"Protein Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1007\/s11010-024-05158-y","article-title":"The Role of Immunoglobins in Atherosclerosis Development; Friends or Foe?","volume":"480","author":"Zhang","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1111\/all.15426","article-title":"The Impact of Type 2 Immunity and Allergic Diseases in Atherosclerosis","volume":"77","author":"Obeso","year":"2022","journal-title":"Allergy"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Herrero-Fernandez, B., Gomez-Bris, R., Somovilla-Crespo, B., and Gonzalez-Granado, J.M. (2019). Immunobiology of Atherosclerosis: A Complex Net of Interactions. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215293"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"106863","DOI":"10.1016\/j.vph.2021.106863","article-title":"Immune Responses against Oxidized LDL as Possible Targets for Prevention of Atherosclerosis in Systemic Lupus Erythematosus","volume":"140","author":"Rattik","year":"2021","journal-title":"Vasc. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.2174\/0109298673301236240311113807","article-title":"We Must Abandon the Myth: Oxidized Low-Density Lipoprotein Is Not a Lipoprotein That Plays a Key Role in Atherogenesis","volume":"32","author":"Orekhov","year":"2025","journal-title":"Curr. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Summerhill, V.I., Grechko, A.V., Yet, S.-F., Sobenin, I.A., and Orekhov, A.N. (2019). The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143561"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Araujo, G., Valencia, L.M., Martin-Ozimek, A., Soto, Y., and Proctor, S.D. (2025). Atherosclerosis: From Lipid-Lowering and Anti-Inflammatory Therapies to Targeting Arterial Retention of ApoB-Containing Lipoproteins. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1485801"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11883-024-01209-3","article-title":"Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease","volume":"26","author":"Akyol","year":"2024","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_12","first-page":"747","article-title":"Electronegative Low-Density Lipoproteins as a Cause of Secondary Cardiovascular Diseases in Chronically Ill Patients\u2014A Method for Identification and Monitoring","volume":"30","author":"Tusheva","year":"2019","journal-title":"Knowl.-Int. J. Sci. Pap."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/S0022-2275(20)32485-8","article-title":"Optimization of the Assay for Sialic Acid Determination in Low Density Lipoprotein","volume":"39","author":"Sobenin","year":"1998","journal-title":"J. Lipid Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0006-291X(89)92163-3","article-title":"Lipoprotein Aggregation as an Essential Condition of Intracellular Lipid Accumulation Caused by Modified Low Density Lipoproteins","volume":"163","author":"Tertov","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.ATV.11.2.316","article-title":"Autoantibodies against Modified Low Density Lipoprotein. Nonlipid Factor of Blood Plasma That Stimulates Foam Cell Formation","volume":"11","author":"Orekhov","year":"1991","journal-title":"Arterioscler. Thromb."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0021-9150(01)00498-1","article-title":"Human Plasma Trans-Sialidase Causes Atherogenic Modification of Low Density Lipoprotein","volume":"159","author":"Tertov","year":"2001","journal-title":"Atherosclerosis"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.2174\/092986733215250325111534","article-title":"The Link between Lipids and Inflammation: Focus on Targeting Sialidase Activity as a Novel Strategy for Anti-Atherosclerotic Therapy","volume":"32","author":"Orekhov","year":"2025","journal-title":"Curr. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1016\/j.bmcl.2004.07.058","article-title":"Specificity of Human Trans-Sialidase as Probed with Gangliosides","volume":"14","author":"Nikonova","year":"2004","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1093\/glycob\/cws057","article-title":"Mammalian Sialidases: Physiological and Pathological Roles in Cellular Functions","volume":"22","author":"Miyagi","year":"2012","journal-title":"Glycobiology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e018756","DOI":"10.1161\/JAHA.120.018756","article-title":"Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low-Density Lipoproteins and Increasing Their Uptake by Macrophages","volume":"10","author":"Demina","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.5114\/amsad.2021.105142","article-title":"Association of Serum Sialic Acid Concentration with Diabetic Complications and Cardiovascular Risk Factors in an Indian Population","volume":"6","author":"Bansal","year":"2021","journal-title":"Arch. Med. Sci. Atheroscler. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3892\/etm.2021.9717","article-title":"Correlations of Sialic Acid with Glycated Hemoglobin A1c and Glycemia in Postmenopausal Women with Type-2 Diabetes Mellitus","volume":"21","author":"Olaru","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Poznyak, A.V., Nikiforov, N.G., Markin, A.M., Kashirskikh, D.A., Myasoedova, V.A., Gerasimova, E.V., and Orekhov, A.N. (2021). Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.613780"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40035-025-00506-4","article-title":"Glycosylation in Neuroinflammation: Mechanisms, Implications, and Therapeutic Strategies for Neurodegenerative Diseases","volume":"14","author":"Cheng","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","article-title":"Residual Cardiovascular Risk Despite Optimal LDL-Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges","volume":"14","author":"Sampson","year":"2012","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41392-023-01690-3","article-title":"Targeting Proprotein Convertase Subtilisin\/Kexin Type 9 (PCSK9): From Bench to Bedside","volume":"9","author":"Bao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_27","first-page":"241","article-title":"PCSK9 Inhibitors in Clinical Practice: Novel Directions and New Experiences","volume":"61","author":"Rallidis","year":"2020","journal-title":"Hell. J. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Malekmohammad, K., Sewell, R.D.E., and Rafieian-Kopaei, M. (2019). Antioxidants and Atherosclerosis: Mechanistic Aspects. Biomolecules, 9.","DOI":"10.3390\/biom9080301"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5470470","DOI":"10.1155\/2019\/5470470","article-title":"The Use of Nutraceuticals to Counteract Atherosclerosis: The Role of the Notch Pathway","volume":"2019","author":"Aquila","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrcardio.2016.103","article-title":"Nutraceutical Therapies for Atherosclerosis","volume":"13","author":"Moss","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Jiang, H., Zhou, Y., Nabavi, S.M., Sahebkar, A., Little, P.J., Xu, S., Weng, J., and Ge, J. (2022). Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.925923"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e12972","DOI":"10.1590\/1414-431x2023e12972","article-title":"Sialic Acid as the Potential Link between Lipid Metabolism and Inflammation in the Pathogenesis of Atherosclerosis","volume":"56","author":"Poznyak","year":"2023","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.immuni.2025.09.012","article-title":"Inflammation in Atherosclerosis: Lessons and Therapeutic Implications","volume":"58","author":"Libby","year":"2025","journal-title":"Immunity"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14689","DOI":"10.1074\/jbc.RA118.004589","article-title":"Sialidase Down-Regulation Reduces Non-HDL Cholesterol, Inhibits Leukocyte Transmigration, and Attenuates Atherosclerosis in ApoE Knockout Mice","volume":"293","author":"White","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Wierzejska, R.E. (2021). Dietary Supplements\u2014For Whom? The Current State of Knowledge about the Health Effects of Selected Supplement Use. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18178897"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.7326\/M19-0341","article-title":"Effects of Nutritional Supplements and Dietary Interventions on Cardiovascular Outcomes an Umbrella Review and Evidence Map","volume":"171","author":"Khan","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1161\/01.CIR.92.7.1758","article-title":"Kuopio Atherosclerosis Prevention Study (KAPS). A Population-Based Primary Preventive Trial of the Effect of LDL Lowering on Atherosclerotic Progression in Carotid and Femoral Arteries","volume":"92","author":"Salonen","year":"1995","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0021-9150(99)00060-X","article-title":"The Antiatherosclerotic Effect of Allium Sativum","volume":"144","author":"Koscielny","year":"1999","journal-title":"Atherosclerosis"},{"key":"ref_40","unstructured":"Orekhov, A.N., Sobenin, I.A., Melnichenko, A.A., Myasoedova, V.A., and Bobryshev, Y.V. (2013). Use of Natural Products for Direct Anti-Atherosclerotic Therapy. Current Trends in Atherogenesis, IntechOpen."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/07853899509031938","article-title":"Direct Anti-Atherosclerosis-Related Effects of Garlic","volume":"27","author":"Orekhov","year":"1995","journal-title":"Ann. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e72053","DOI":"10.1002\/fsn3.72053","article-title":"3\u2032-Sialyllactose Prevents Atherosclerosis by Attenuating Chronic Inflammation via the Gut-Immune-Cardiovascular Axis in LDLR\u2212\/\u2212 Mice","volume":"14","author":"Zhuang","year":"2026","journal-title":"Food Sci. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11883-026-01421-3","article-title":"Desialylated vs. Oxidized LDL: Sialidase Inhibitors as Promising Antiatherosclerotic Agents","volume":"28","author":"Orekhov","year":"2026","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e70236","DOI":"10.1111\/cts.70236","article-title":"Enhancement of Statin Effects on Lipid Lowering and Reduction of Cardiovascular Risk Score by (\u2212)-Epicatechin in Proof-of-Concept Pilot Study","volume":"18","author":"Ormiston","year":"2025","journal-title":"Clin. Transl. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"118552","DOI":"10.1016\/j.biopha.2025.118552","article-title":"Oral Nutraceutical Intervention to Improve Endothelial Function: Evidence from in Vitro and Pilot Clinical Studies","volume":"191","author":"Valerio","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.RES.66.2.311","article-title":"Triggerlike Stimulation of Cholesterol Accumulation and DNA and Extracellular Matrix Synthesis Induced by Atherogenic Serum or Low Density Lipoprotein in Cultured Cells","volume":"66","author":"Orekhov","year":"1990","journal-title":"Circ. Res."},{"key":"ref_48","first-page":"530265","article-title":"Effects of Glycyrrhizic Acid on Peroxisome Proliferator-Activated Receptor Gamma (PPARgamma), Lipoprotein Lipase (LPL), Serum Lipid and HOMA-IR in Rats","volume":"2010","year":"2010","journal-title":"PPAR Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1021\/jm301892f","article-title":"Identification of Selective Inhibitors for Human Neuraminidase Isoenzymes Using C4,C7-Modified 2-Deoxy-2,3-didehydro-N-acetylneuraminic Acid (DANA) Analogues","volume":"56","author":"Zhang","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Schengrund, C.-L. (2025). Sialidases as Potential Therapeutic Targets for Treatment of a Number of Human Diseases. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26178733"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Duan, J., Guo, X., Sun, P., Zhou, H., and He, X. (2026). Research Progress and Screening Strategies of Natural Product-Derived Neuraminidase Inhibitors. Biosensors, 16.","DOI":"10.3390\/bios16070365"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.3390\/cimb46080475","article-title":"Neuraminidase-1 (NEU1): Biological Roles and Therapeutic Relevance in Human Disease","volume":"46","author":"Du","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"111318","DOI":"10.1016\/j.compbiomed.2025.111318","article-title":"A Network Pharmacology and in Silico Approach to Target NEU1-Mediated Microglial Activation in Neuroinflammation: Validation in an LPS-Induced Mouse Model","volume":"199","author":"Alzarea","year":"2025","journal-title":"Comput. Biol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"39901","DOI":"10.1038\/s41598-025-22955-7","article-title":"Identification of Novel Neuraminidase 1 Modulators as Potential Therapeutics for Alzheimer\u2019s Disease Using Virtual Screening and Molecular Dynamics Simulations","volume":"15","author":"Alzarea","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_55","first-page":"100064","article-title":"NEU1 and NEU3 Enzymes Alter CD22 Organization on B Cells","volume":"2","author":"Li","year":"2022","journal-title":"Biophys. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Smutova, V., Albohy, A., Pan, X., Korchagina, E., Miyagi, T., Bovin, N., Cairo, C.W., and Pshezhetsky, A.V. (2014). Structural Basis for Substrate Specificity of Mammalian Neuraminidases. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0106320"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1016\/j.bmcl.2010.09.111","article-title":"Inhibition of Human Neuraminidase 3 (NEU3) by C9-Triazole Derivatives of 2,3-Didehydro-N-Acetyl-Neuraminic Acid","volume":"20","author":"Zou","year":"2010","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jmgm.2005.12.006","article-title":"Homology Modeling of Human Sialidase Enzymes NEU1, NEU3 and NEU4 Based on the Crystal Structure of NEU2: Hints for the Design of Selective NEU3 Inhibitors","volume":"25","author":"Magesh","year":"2006","journal-title":"J. Mol. Graph. Model."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1107\/S1399004714002971","article-title":"Structural Basis of Sialidase in Complex with Geranylated Flavonoids as Potent Natural Inhibitors","volume":"70","author":"Lee","year":"2014","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_60","first-page":"234","article-title":"Novel pH-Dependent Regulation of Human Cytosolic Sialidase 2 (NEU2) Activities by Siastatin B and Structural Prediction of NEU2\/Siastatin B Complex","volume":"4","author":"Rahman","year":"2015","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Xu, X., and Zou, X. (2026). Docking-Based Virtual Screening: Past, Present, and Future. Biophys. J.","DOI":"10.1016\/j.bpj.2026.04.011"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/AAC.00344-08","article-title":"Limited Inhibitory Effects of Oseltamivir and Zanamivir on Human Sialidases","volume":"52","author":"Hata","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.2174\/1381612824666180910125051","article-title":"Diagnostics and Therapy of Human Diseases\u2014Focus on Sialidases","volume":"24","author":"Karagodin","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Hayre, J.K., Xu, G., Borgianni, L., Taylor, G.L., Andrew, P.W., Docquier, J.-D., and Oggioni, M.R. (2012). Optimization of a Direct Spectrophotometric Method to Investigate the Kinetics and Inhibition of Sialidases. BMC Biochem., 13.","DOI":"10.1186\/1471-2091-13-19"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1039\/D5FO04031K","article-title":"N-Acetylneuraminic acid and 3\u2032-sialyllactose supplementation unlock shared and unique atheroprotective mechanisms through the gut\u2013liver\u2013coronary axis in hypercholesterolemic LDLR\u2212\/\u2212 mice","volume":"17","author":"Zhang","year":"2026","journal-title":"Food Funct."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1038\/s41598-022-07033-6","article-title":"Defect in Cytosolic Neu2 Sialidase Abrogates Lipid Metabolism and Impairs Muscle Function in Vivo","volume":"12","author":"Oh","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2183\/pjab.84.407","article-title":"Aberrant Expression of Sialidase and Cancer Progression","volume":"84","author":"Miyagi","year":"2008","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Jagim, A.R., Harty, P.S., Erickson, J.L., Tinsley, G.M., Garner, D., and Galpin, A.J. (2023). Prevalence of Adulteration in Dietary Supplements and Recommendations for Safe Supplement Practices in Sport. Front. Sports Act. Living, 5.","DOI":"10.3389\/fspor.2023.1239121"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/9\/1319\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:23:48Z","timestamp":1789187028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/9\/1319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":68,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["biom16091319"],"URL":"https:\/\/doi.org\/10.3390\/biom16091319","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}